Rituximab Biosimilars May Be Cost-Effective Treatment for Pemphigus Vulgaris
The cost effectiveness of rituximab biosimilars vs mycophenolate mofetil for the treatment of pemphigus vulgaris is investigated.
News
Latest News
Demodex Mites With T-Cell Exhaustion in Rosacea Patients With Papulopustules
The role of Demodex mites in the cause, development of papulopustular rosacea is analyzed to see if rosacea could be credited to Demodex proliferation.
Opioid and Benzodiazepine Co-Use at the ED May Have Long-Term Negative Health Impacts
The study authors explored whether exposure to opioids and benzodiazepines in emergency traumatic injury care is associated with long-term substance use and negative mental health outcomes.
Digital Eye Strain Risk Factors Identified
Investigators identify dry eye disease risk factors observed in individuals who view digital screens for extended periods of time.
For Self-Measured BP, Smartphone App No Better Than Standard Device
Enhanced self-measured blood pressure (SMBP) paired with a connected smartphone application is not superior to standard SMBP for reducing BP.
Text Message Reminders Promote Receipt of Second Flu Shot
Text message reminders effectively promote receipt of a second dose of influenza vaccine among children.
Multifaceted Approach Urged for Promoting Helmet Use for Children
A multifaceted approach is recommended to promote helmet use among children and youth participating in recreational sports in order to prevent head injuries.
Concomitant Methamphetamine, Opioids Use Tied to Increase in Nonfatal Overdoses
Methamphetamine and opioid co-users are more likely to have nonfatal overdoses compared with users of either drug alone.
Current Understanding of Rosacea and the Potential Therapeutic Targets
The most recent evidence and understanding of rosacea therapeutic targets are reviewed.
Acne and Increased Psychological and Physical Burden
The psychosocial burden of facial and truncal acne and acne scars are investigated.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...